Congenital Hyperinsulinism: Clinical Trials

1 trial for Congenital Hyperinsulinism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow Congenital Hyperinsulinism: new trials by email Literature Review of Congenital Hyperinsulinism trials Research Report on Congenital Hyperinsulinism

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Exendin (9-39) on Glucose Requirements to Maintain Euglycemia
Exendin (9-39), Vehicle - Congenital Hyperinsulinism
Phase 1 / Phase 2TerminatedDiva De Leon142009-08-262020-06-01

Narrower conditions

Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Hypoglycemia (1)  ·  Infant, Newborn, Diseases (1)  ·  Metabolic Diseases (1)  ·  Pancreatic Diseases (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

exendin (9-39) (1)

Sponsors

Diva De Leon (1)

Countries

United States (1)

Top investigators

Diva D De Leon, MD MSCE (1)